XML 35 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2015
Fair Value Disclosures [Abstract]  
Summary of Financial Instruments Measured at Fair Value on Recurring Basis
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):
 
Fair Value Measurements at December 31, 2015
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Money market fund
$
3,803,929

 
$
3,803,929

 

 

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Series A warrant liability
1,212,803

 
1,212,803

 

 

Series B warrant liability
865,000

 

 

 
865,000

Series C warrant liability
462,437

 

 

 
462,437

    Total common stock warrant liability
$
2,540,240

 
$
1,212,803

 

 
$
1,327,437

 
 
 
 
 
 
 
 
 
Fair Value Measurements at December 31, 2014
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Money market fund
$
7,891,888

 
$
7,891,888

 
$

 
$

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Series A warrant liability
857,362

 
857,362

 

 

Series B warrant liability
17,438,731

 

 

 
17,438,731

    Total common stock warrant liability
$
18,296,093

 
$
857,362

 

 
$
17,438,731

Summary of Changes in Fair Value of Level1 and Level 3 Financial Instruments
The following table sets forth a summary of the changes in the fair value of the Company’s Level 1 and Level 3 financial instruments, which are treated as liabilities, as follows:
 
Series A Warrant
 
Series B Warrant
 
Series C Warrant
 
Number of Warrants
 
Liability
 
Number of Warrants
 
Liability
 
Number of Warrants
 
Liability
Balance at December 31, 2014
2,449,605

 
$
857,362

 
2,449,605

 
$
17,438,731

 

 
$

Change in value of Series A Warrants

 
397,441

 

 

 

 

De-recognition of Series A Warrant liability upon exercise
(24,000
)
 
(42,000
)
 

 

 

 

De-recognition of Series B Warrant liability upon cash exercise of 619,512 warrants in Private Transaction (619,512 shares issued)

 

 
(619,512
)
 
(6,747,765
)
 

 

De-recognition of Series B Warrant liability upon cashless exercise of 1,713,045 warrants (5,879,560 shares issued)

 

 
(1,713,045
)
 
(12,527,991
)
 

 

De-recognition of Series B Warrant liability upon contribution of 468 warrants back to the Company

 

 
(468
)
 
(3,332
)
 

 

Change in value of Series B Warrants

 

 

 
2,705,357

 

 

Record Series C Warrant Liability as inducement charge (589,510 warrants in Private Transaction, 905 warrants in tender offer )

 

 

 

 
590,415

 
3,049,375

Change in value of Series C Warrants

 

 

 

 

 
(2,586,938
)
Balance at December 31, 2015
2,425,605

 
$
1,212,803

 
116,580

 
$
865,000

 
590,415

 
$
462,437